These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 7699982

  • 1. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [Abstract] [Full Text] [Related]

  • 2. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [Abstract] [Full Text] [Related]

  • 3. [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611].
    Tomioka H, Sato K, Saito H, Ikeda Y.
    Kekkaku; 1992 Jul; 67(7):515-20. PubMed ID: 1331603
    [Abstract] [Full Text] [Related]

  • 4. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [Abstract] [Full Text] [Related]

  • 5. [In vitro antimycobacterial activities of a new quinolone, balofloxacin].
    Kawahara S, Tada A, Nagare H.
    Kekkaku; 2001 Jan; 76(1):29-31. PubMed ID: 11211780
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic potential of sparfloxacin for preventing mycobacterial infections].
    Kawahara S, Tada A, Takeuchi M, Kamisaka K, Okada C, Mishima Y, Soda R, Takahashi K, Kibata M, Nagare H.
    Kekkaku; 1994 May; 69(5):351-6. PubMed ID: 8007520
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S, Tada A, Nagare H.
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antimicrobial activity of a new quinolone, levofloxacin, against atypical mycobacteria].
    Oya S, Takemoto A, Hosaka K, Kudou Y, Arakawa M.
    Kekkaku; 1995 Nov; 70(11):615-9. PubMed ID: 8656585
    [Abstract] [Full Text] [Related]

  • 9. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
    Tomioka H, Saito H, Sato K.
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H, Sato K, Saito H.
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI.
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [Abstract] [Full Text] [Related]

  • 13. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Dec; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 14. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H, Sato K, Tomioka H, Dekio S.
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [Abstract] [Full Text] [Related]

  • 15. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M, Petitpain N, Henry C, Weber M.
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [Abstract] [Full Text] [Related]

  • 16. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.
    Saito H, Tomioka H, Sato K, Dekio S.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2877-82. PubMed ID: 7695276
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N, Nakasone I, Saitoh H, Kaneda M, Shimojima M, Yamashita K, Toyoda K, Okazawa Y.
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.
    Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):542-7. PubMed ID: 2039206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.